Based on our bioinformatics analysis revealing the significant upregulation of AMBRA1 in STAD and its correlation with poor prognosis (Figures 1E–G), we sought to validate these clinical observations and explore the functional role of AMBRA1 through a series of in vitro experiments using STAD cell lines. Here, AMBRA1 is linked to gastric adenocarcinoma.